Celldex Therapeutics Inc

2026. okt. 22. 19:56 UTC

Shares of Celldex Therapeutics Inc are declining amid negative market reaction to Moderna's cancer vaccine trial results, impacting the SPDR S&P Biotech ETF (XBI).

2026. okt. 21. 19:46 UTC

Celldex Therapeutics Inc shares are declining, having pulled back from earlier gains amid broader market weakness and trading significantly below its 20-day moving average.

2026. okt. 20. 20:31 UTC

Celldex Therapeutics Inc shares are trading lower in after-market hours, shifting from an initial gain to a notable loss since Tuesday's close.

2026. okt. 19. 20:01 UTC

Celldex Therapeutics Inc shares are trading significantly higher, reaching a notable peak late morning before a slight retracement amid recent declines.

2026. okt. 16. 20:01 UTC

Celldex Therapeutics Inc shares are declining amid a broader downturn in the biotechnology sector, as the SPDR S&P Biotech ETF (XBI) also falls.

2026. okt. 15. 19:26 UTC

The SPDR S&P Biotech ETF is trading higher, supported by analyst upgrades for biotech firms, including Goldman Sachs' price target raise for Moderna.

2026. okt. 14. 23:36 UTC

Celldex Therapeutics Inc experienced a modest decline during after-market hours on Wednesday, continuing a pattern of lower daily closes and remaining below its 20-day moving average.

2026. okt. 13. 20:01 UTC

Celldex Therapeutics shares are declining, following a brief rebound earlier in the session, as the SPDR S&P Biotech ETF also faces losses.

2026. okt. 9. 19:46 UTC

Shares of Celldex Therapeutics Inc are advancing, supported by a rise in the SPDR S&P Biotech ETF following gains from Moderna amid cancer vaccine partnership news.

2026. okt. 8. 20:07 UTC

Celldex Therapeutics Inc shares are declining, reflecting broader market weakness amid significant downturns and ongoing challenges, remaining well below the 20-day moving average.

2026. okt. 6. 20:00 UTC

Celldex Therapeutics Inc shares fell amid a broader biotechnology sector decline, influenced by Federal Reserve comments on inflation risks and a widening U.S. trade deficit.

2026. okt. 5. 20:01 UTC

Celldex Therapeutics Inc is advancing, regaining momentum after pulling back earlier, amid unusual strength while trading near the lower end of its one-month range.

2026. okt. 2. 20:00 UTC

Celldex Therapeutics Inc shares fell more than two percent, reversing earlier gains and remaining significantly below its 20-day moving average.

2026. okt. 1. 19:46 UTC

Celldex Therapeutics Inc shares fell, continuing a trend from Wednesday, amid a slight downturn in the State Street SPDR S&P Biotech ETF.

2026. szept. 30. 23:45 UTC

Celldex Therapeutics Inc is rising in after-market trading, gaining ground since Wednesday's close, despite remaining below its 20-day moving average.

2026. szept. 29. 19:46 UTC

Celldex Therapeutics Inc shares are higher today after positive feedback on Barzolvolimab, with analysts raising the price target to $64 per share.

2026. szept. 28. 22:35 UTC

Celldex Therapeutics Inc is trading modestly higher in after-market hours, recovering from an early dip but remains below its 20-day moving average.

2026. szept. 25. 19:20 UTC

Celldex Therapeutics Inc shares fell sharply after an early high, currently trading below Thursday's close and notably under its 20-day moving average.

2026. szept. 23. 20:02 UTC

Celldex Therapeutics shares fell sharply amid safety concerns from its Phase 3 CSU study, despite Overweight ratings from Morgan Stanley and Leerink Partners.

2026. szept. 22. 23:06 UTC

Celldex Therapeutics Inc is seeing a modest increase in after-market trading, recovering from an earlier session low and gaining since Tuesday's close.

2026. szept. 21. 20:01 UTC

Celldex Therapeutics Inc shares fell sharply, diverging from recent gains as the biotechnology sector shows varied performance.

2026. szept. 18. 20:02 UTC

Celldex Therapeutics Inc shares fell sharply, remaining well below their 20-day moving average after a notable high earlier in the session.

2026. szept. 17. 20:07 UTC

Celldex Therapeutics Inc is modestly higher in Thursday's session, rebounding from an earlier pullback, amid a boost from positive developments in the biotech sector.

2026. szept. 16. 20:10 UTC

Celldex Therapeutics Inc is advancing in Wednesday's market session, showing modest gains since Tuesday, despite pulling back from earlier session highs.

2026. szept. 15. 20:07 UTC

Celldex Therapeutics Inc shares are lower amid sector-wide weakness in biotechnology, influenced by rising yields and Federal Reserve concerns.

2026. szept. 14. 20:03 UTC

Celldex Therapeutics Inc shares are higher today, with no specific news identified. Rising crude oil prices contribute to broader market inflation concerns ahead of the Fed's decision.

2026. szept. 11. 20:08 UTC

Celldex Therapeutics Inc shares are lower today, continuing a five-session decline. The stock is trading significantly below its 20-day moving average.

2026. szept. 10. 19:26 UTC

Celldex Therapeutics Inc shares are lower, reflecting bearish sentiment in the biotechnology sector. The stock remains below its 20-day moving average.

2026. szept. 8. 20:07 UTC

Celldex Therapeutics Inc shares are lower today, reflecting ongoing performance weakness amid speculation about a potential Federal Reserve interest rate hike.

2026. aug. 28. 20:03 UTC

Celldex Therapeutics Inc. shares are lower today, breaking a trend of higher closes. Broader market conditions may be influencing this shift.